Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 5/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.44 |
| ▸ | EGLN2 | Q96KS0 | 5/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.39 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.39 |
| ▸ | MTOR | P42345 | 1/20 | 0.39 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.36 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 1/20 | 0.35 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.35 |
| ▸ | CTSA | P10619 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25992013 | 0.85 | ADORA1 (0.58) | ADORA1ADORA2AADORA2BKDM1A | |
| SCHEMBL25992005 | 0.79 | STS (0.38) | ADORA1ADORA2ACYP11B1CYP11B2ADORA2B | |
| SCHEMBL25991994 | 0.73 | ADORA1 (0.34) | ADORA1ADORA2AADORA2B | |
| SCHEMBL4910033 | 0.72 | PDE9A (0.42) | EGLN2CYP11B1CYP11B2PIK3CDPIK3R1 | |
| SCHEMBL25992009 | 0.71 | ADORA1 (0.44) | ADORA1ADORA2AADORA2B | |
| SCHEMBL25991999 | 0.70 | ADORA1 (0.35) | ADORA1ADORA2AADORA2B | |
| SCHEMBL25991972 | 0.70 | ADORA1 (0.34) | ADORA1ADORA2AADORA2B | |
| SCHEMBL31677786 | 0.70 | EGLN2 (0.42) | ADORA1ADORA2AEGLN2CYP11B1CYP11B2 | |
| SCHEMBL20792031 | 0.70 | EGLN2 (0.49) | EGLN2CYP11B1CYP11B2SLC22A12 | |
| SCHEMBL319603 | 0.69 | CTSA (0.46) | EGLN2CYP11B1CYP11B2SLC22A12PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263053-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | PPOX, CRY1, CRY2 | ADORA1 3376/4885ADORA2A 1718/4885EGLN2 4056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.